Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015, we hereby inform that Company has announced the launch of its next generation 20-valent Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) I.P., 20 - valent (PCV20) for adults in India, on August 11, 2025.